Anirvan Ghosh
Net Worth

Last updated:

What is Anirvan Ghosh net worth?

The estimated net worth of Dr. Anirvan Ghosh is at least $2,368,365 as of 2 May 2024. He owns shares worth $13,753 as insider, has earned $78,902 from insider trading and has received compensation worth at least $2,275,710 in Unity Biotechnology, Inc..

What is the salary of Anirvan Ghosh?

Dr. Anirvan Ghosh salary is $758,570 per year as Chief Executive Officer & Director in Unity Biotechnology, Inc..

How old is Anirvan Ghosh?

Dr. Anirvan Ghosh is 61 years old, born in 1964.

What stocks does Anirvan Ghosh currently own?

As insider, Dr. Anirvan Ghosh owns shares in one company:

Company Title Shares Price per share Total value
Unity Biotechnology, Inc. (UBX) Chief Executive Officer & Director 78,143 $0.18 $13,753

What does Unity Biotechnology, Inc. do?

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

UBX logo
UBX
Unity Biotechnology, Inc.
$0.18

Anirvan Ghosh insider trading

Unity Biotechnology, Inc.

Dr. Anirvan Ghosh has made 21 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 603 units of UBX stock worth $935 on 2 May 2024.

The largest trade he's ever made was exercising 13,706 units of UBX stock on 14 Sep 2022. As of 2 May 2024 he still owns at least 78,143 units of UBX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $0.0001 par value 603 $1.55 $935
Sale
Common Stock, $0.0001 par value 680 $1.71 $1,163
Sale
Common Stock, $0.0001 par value 1,183 $1.71 $2,023
Sale
Common Stock, $0.0001 par value 589 $1.83 $1,078
Sale
Common Stock, $0.0001 par value 1,024 $1.9 $1,946
Sale
Common Stock, $0.0001 par value 1,246 $2.47 $3,078
Sale
Common Stock, $0.0001 par value 581 $2.94 $1,708
Sale
Common Stock, $0.0001 par value 1,020 $2.86 $2,917
Sale
Common Stock, $0.0001 par value 1,177 $3.2 $3,766
Sale
Common Stock, $0.0001 par value 1,212 $3.39 $4,109
Sale
Common Stock, $0.0001 par value 588 $2.17 $1,276
Sale
Common Stock, $0.0001 par value 1,020 $2.15 $2,193
Sale
Common Stock, $0.0001 par value 1,959 $1.7 $3,330
Sale
Common Stock, $0.0001 par value 1,210 $4 $4,840
Sale
Common Stock, $0.0001 par value 2,573 $4.84 $12,453
Sale
Common Stock, $0.0001 par value 1,140 $4.45 $5,073
Sale
Common Stock, $0.0001 par value 1,274 $2.85 $3,631
Sale
Common Stock, $0.0001 par value 1,099 $2.4 $2,638
Sale
Common Stock, $0.0001 par value 13,706 $0.48 $6,579
Sale
Common Stock, $0.0001 par value 10,446 $0.67 $6,999
Sale
Common Stock, $0.0001 par value 12,149 $0.59 $7,168

Unity Biotechnology key executives

Unity Biotechnology, Inc. executives and other stock owners filed with the SEC: